Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Hospital Activity	286.26M	231.99M	217.38M	198.77M	156.95M
Hospital Activity Growth	23.39%	6.72%	9.36%	26.64%	57.32%
Sale of Product Activity	716.24M	561.16M	632.19M	597.92M	446.39M
Sale of Product Activity Growth	27.64%	-11.24%	5.73%	33.94%	27.48%
Unallocable	66.57M	77.95M	123.90M	195.00M	143.72M
Unallocable Growth	-14.61%	-37.08%	-36.46%	35.68%	97.39%
Total	1.07B	871.10M	973.47M	991.69M	747.07M
Total Growth	22.73%	-10.52%	-1.84%	32.74%	42.91%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
India	1.07B	898.47M	993.31M	991.69M	747.11M
India Growth	18.99%	-9.55%	0.16%	32.74%	42.92%
Total	1.07B	898.47M	993.31M	991.69M	747.11M
Total Growth	18.99%	-9.55%	0.16%	32.74%	42.92%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 12, 2026

Data Sources Report a data error